|
ZNF613 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.377400E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.058140E-02 |
| Normal-vs-Stage2 |
5.054200E-02 |
| Normal-vs-Stage3 |
3.795900E-03 |
| Normal-vs-Stage4 |
1.84923999999587E-05 |
| Stage1-vs-Stage2 |
8.941400E-01 |
| Stage1-vs-Stage3 |
1.702390E-01 |
| Stage1-vs-Stage4 |
1.601060E-03 |
| Stage2-vs-Stage3 |
2.271800E-01 |
| Stage2-vs-Stage4 |
9.504900E-03 |
| Stage3-vs-Stage4 |
1.732030E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.424850E-03 |
| Normal-vs-AfricanAmerican |
2.063000E-01 |
| Normal-vs-Asian |
1.256320E-02 |
| Caucasian-vs-AfricanAmerican |
5.103800E-01 |
| Caucasian-vs-Asian |
5.272800E-01 |
| AfricanAmerican-vs-Asian |
7.826000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.858400E-02 |
| Normal-vs-Female |
2.759000E-04 |
| Male-vs-Female |
2.363000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.764300E-02 |
| Normal-vs-Age(41-60Yrs) |
4.415900E-03 |
| Normal-vs-Age(61-80Yrs) |
4.246800E-04 |
| Normal-vs-Age(81-100Yrs) |
1.861410E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.450400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.449900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.998000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.946400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.318600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.620200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.42539999999658E-05 |
| Classical-VS-Follicular |
8.348400E-01 |
| Classical-VS-Other |
6.337200E-01 |
| Classical-VS-Normal |
6.442800E-03 |
| Tall-VS-Follicular |
1.779780E-03 |
| Tall-VS-Other |
2.093600E-01 |
| Tall-VS-Normal |
5.39870000038079E-07 |
| Follicular-VS-Other |
7.759800E-01 |
| Follicular-VS-Normal |
6.205700E-02 |
| Other-VS-Normal |
5.712800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.026300E-02 |
| Normal-vs-N1 |
5.80179999999375E-05 |
| N0-vs-N1 |
5.843700E-03 |
|
|
